Table 1 Laboratory and clinical characteristics of newly diagnosed active MPO-AAV patients and healthy control before treatment

n

143

176

Age (Y), mean (range)

60 (52–86)

53 (40–75)

Gender (F/M)

69/74

90/86

MPO-ANCA titer, (median, range)

94.97 (18.37–167.98)

-

White blood cells (10⁹/l) (mean, SD)

8.70±3.57

6.05±1.11

Neutrophil (10⁹/l) (mean, SD)

6.81±3.36

3.49±0.83

Neutrophil percentage (%) (mean, SD)

76.22±9.46

57.14±7.40

Lymphocyte (10⁹/l) (mean, SD)

1.10±0.54

2.01±0.45

Lymphocyte percentage (%) (mean, SD)

14.09±7.39

33.46±5.74